Atlas Trials

Sepsis

1,588 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Sepsis

RecordFirmDate
Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (NCT00159510)Northern State Medical University2004-04-01
Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn (NCT00136370)Centers for Disease Control and Prevention2004-04-01
Low-Dose Endotoxemia and the Acute Phase Response (NCT00197899)Herlev Hospital2004-03-01
Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia (NCT02544230)Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne2004-01-01
Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants (NCT00189384)Aga Khan University2003-11-01
Dose-response Study of Arginine Supplementation in Severe Sepsis (NCT01775020)Maastricht University Medical Center2003-10-01
Genetic Variation and Immune Responses After Injury (NCT00294697)National Institute of General Medical Sciences (NIGMS)2003-08-01
The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit (NCT00282594)Genesys2003-07-01
Prevention of Infection in Indian Neonates - Phase I Observational Study (NCT00518609)NICHD Global Network for Women's and Children's Health2003-07-01
The Effects of HIV Protease Inhibitors in Severe Sepsis (NCT00346580)Mayo Clinic2003-06-01
A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation (NCT00067730)Eli Lilly and Company2003-03-01
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis (NCT00222222)Universitätsmedizin Mannheim2003-03-01
A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated) (NCT00049777)Eli Lilly and Company2002-12-01
Regression Discontinuity Design to Evaluate of Drotrecogin Alpha Effectiveness (NCT02843685)Boston Medical Center2002-12-01
The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death (NCT00568737)Eli Lilly and Company2002-11-01
Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis (NCT00049764)Eli Lilly and Company2002-11-01
The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis (NCT00045760)Eli Lilly and Company2002-09-01
Antibiotic/COPD in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Requiring Mechanical Ventilation (NCT00791505)University of Monastir2002-07-01
A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis (NCT00042588)ICOS Corporation2002-05-01
Mild Therapeutic Hypothermia During Severe Sepsis (NCT01069146)University Hospital, Brest2002-01-01
Pharmacoeconomic Analysis of First Line Meropenem Versus Standard Antibiotic Treatment in Seriously Infected Secondary Nosocomial Sepsis Syndrome Patients. (NCT00318552)Pfizer2002-01-01
Indicators of Inflammation and Coagulation in Sepsis (NCT01128283)University of Oklahoma2002-01-01
A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis (NCT00046072)Eisai Inc.2001-10-01
A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis (NCT00034476)Eli Lilly and Company2001-10-01
Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe Sepsis (NCT00037687)ICOS Corporation2001-04-01
Leukocyte Depletion of Autologous Whole Blood (NCT00176124)Heidelberg University2001-04-01
Botswana Pediatric Respiratory Disease and Bloodstream Infection Study (NCT00197691)Harvard School of Public Health (HSPH)2001-03-01
Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure (NCT00016523)NICHD Neonatal Research Network2001-01-01
Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections (NCT00027248)BioWest Therapeutics Inc2000-09-01
Sepsis As a Cause of Death Among Elderly Cancer Patients (NCT06619535)asmaa salama ibrahim2000-01-01
Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants (NCT00005775)NICHD Neonatal Research Network1999-07-01
Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia (NCT00548002)University of Helsinki1999-01-01
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis (NCT00004494)Stony Brook University1998-09-01
Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis (NCT00406198)Hopital Lariboisière1997-03-01
Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight Infants (NCT00005888)National Center for Research Resources (NCRR)1997-01-01
Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants (NCT01203488)NICHD Neonatal Research Network1996-01-01
A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer (NCT00001338)National Cancer Institute (NCI)1993-06-01
Adrenal Cortical Function and Vitamin A Deficiency in Sepsis (NCT03152474)Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center1993-02-01
Effects of Endotoxin in Normal Human Volunteers (NCT00001303)National Institutes of Health Clinical Center (CC)1992-04-06
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection (NCT01203345)NICHD Neonatal Research Network1988-01-01
Procalcitonin Guided Versus Conventional Antibiotic Therapy in Patients With Sepsis in the ICU (NCT00987818)Rijnstate Hospital
← Previous Next →

Track Sepsis automatically

Every clearance here is in the API, with alerts when new ones post.